Partnerships 2010: Chairperson’s Welcome and Introduction of Day Two

Jack Dean, Ph.D., Sc.D. (Hon.), DABT, Fellow ATS, President, DRUG DEVELOPMENT ADVISORS, LLC; Professor, Colleges of Pharmacy & Medicine, University of Arizona; President US R&D, Sanofi-Aventis (Retired)

After a busy and productive Day One, event chairman Jack Dean welcomed conference attendees back for the final day of the Partnerships conference. Dean presented some highlights from Day One’s different topical session tracks.

In Track A, CRO financial outlook is looking better and there is a move towards more strategic relationships. In Track B, it was agreed that there is a need for auditing for CROs and data should not be relied on alone. In Track C, there was a focus on safety and risk management and the use of REMS, as well as a close look at conducting trials outside the US. Track D looked at early clinical development, specifically looking at biomarkers, the use of eCTDs, and the changes in paradigms in oncology. Track E looked closely at cost management.

Dean then looked ahead to Day Two, with a couple of exciting keynote talks before the session tracks open for the day.